Position in TLRY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,532
-$41,937 QoQ
Shares Held
16,377
-8.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 235 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 3%
Shared 30%
None 67%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $67,490,391 across 30 Drug Manufacturers - Specialty & Generic names. TLRY ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
123,778 | $20,861,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,210 | $10,950,383 | |
| 3 | ZTS |
Zoetis Inc.
|
90,284 | $6,487,806 | |
| 4 | VTRS |
Viatris Inc
|
280,668 | $4,457,007 | |
| 5 | HLN |
Haleon plc
|
443,467 | $4,137,546 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
106,508 | $3,608,490 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
184,772 | $2,677,345 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
40,488 | $2,589,207 |
All Filings in TLRY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,532 | 16,377 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $115,469 | 17,847 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $173,880 | 100,509 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $37,949 | 92,560 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $30,776 | 46,631 | Shares | Sole | 2025-04-30 | |
| 2024-06-30 | $21,772 | 13,116 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,340 | 13,498 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,796 | 15,129 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||